Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension

Withdrawn

Conditions: Hypertension

First Posted Date: 2010-12-15

Last Posted Date: 2013-05-14

Lead Sponsor: Pfizer

Registration Number: NCT01260857

A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.

Phase 1

Completed

Conditions: Bioequivalence
Ethinylestradiol
Gestodene
Harmonet

Interventions: Drug: Reference Drug
Drug: Test Drug

First Posted Date: 2010-12-15

Last Posted Date: 2011-02-21

Lead Sponsor: Pfizer

Target Recruit Count: 32

Registration Number: NCT01260805

Locations: 🇧🇷
Pfizer Investigational Site, Aparecida de Goiania, GO, Brazil

Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

Completed

Conditions: Over Active Bladder

Interventions: Drug: Fesoterodine

First Posted Date: 2010-12-15

Last Posted Date: 2014-09-11

Lead Sponsor: Pfizer

Target Recruit Count: 508

Registration Number: NCT01260311

Locations: 🇵🇭
Mary Johnston Hospital, Inc., Tondo, Manila, Philippines
🇵🇭
The Medical City, Pasig City, Metro Manila, Philippines
🇵🇭
St. Luke's Medical Center, Quezon City, Metro Manila, Philippines

and more 21 locations

A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy Volunteers

Phase 1

Completed

Conditions: Pain

Interventions: Drug: PF-05089771

First Posted Date: 2010-12-14

Last Posted Date: 2012-02-02

Lead Sponsor: Pfizer

Target Recruit Count: 61

Registration Number: NCT01259882

Locations: 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium

Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes

Phase 3

Completed

Conditions: Spondylitis, Ankylosing

Interventions: Biological: etanercept
Other: PLACEBO
Drug: Background NSAID

First Posted Date: 2010-12-13

Last Posted Date: 2015-10-19

Lead Sponsor: Pfizer

Target Recruit Count: 225

Registration Number: NCT01258738

Locations: 🇫🇷
CHU Lapeyronie, Immuno-Rhumatologie, Montpellier, France
🇧🇪
Reuma Instituut, Hasselt, Belgium
🇨🇴
Servimed Sas, Bucaramanga, Santander, Colombia

and more 47 locations

This Study Will Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-05212377

First Posted Date: 2010-12-13

Last Posted Date: 2011-07-06

Lead Sponsor: Pfizer

Target Recruit Count: 12

Registration Number: NCT01258751

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

Safety Study of Ointment for the Treatment of Plaque-type Psoriasis

Phase 1

Completed

Conditions: Plaque-type Psoriasis

Interventions: Drug: AN2728 Ointment
Drug: AN2728 Vehicle

First Posted Date: 2010-12-10

Last Posted Date: 2019-03-05

Lead Sponsor: Pfizer

Target Recruit Count: 16

Registration Number: NCT01258088

Locations: 🇦🇺
CMAX (A Division of IDT Australia Ltd), Adelaide, Australia

Acute Cough Study In Children

Phase 4

Terminated

Conditions: Common Cold
Infections, Upper Respiratory Tract

Interventions: Drug: Dextromethorphan
Drug: Placebo

First Posted Date: 2010-12-09

Last Posted Date: 2012-09-20

Lead Sponsor: Pfizer

Target Recruit Count: 140

Registration Number: NCT01257542

Locations: 🇺🇸
DMI Research, Pinellas, Florida, United States
🇺🇸
Cyn3rgy Research, Gresham, Oregon, United States
🇺🇸
Clinical Research Associates Incorporated, Nashville, Tennessee, United States

and more 1 locations

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

Phase 2

Terminated

Conditions: HIV-1

Interventions: Drug: lersivirine
Drug: etravirine
Drug: efavirenz

First Posted Date: 2010-12-06

Last Posted Date: 2014-06-09

Lead Sponsor: Pfizer

Target Recruit Count: 108

Registration Number: NCT01254656

Locations: 🇬🇧
Pfizer Investigational Site, London, United Kingdom

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-05212365

First Posted Date: 2010-12-03

Last Posted Date: 2011-04-28

Lead Sponsor: Pfizer

Target Recruit Count: 6

Registration Number: NCT01253655

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy